Literature DB >> 6603195

Effects of penicillinase on bactericidal and complement activities in normal human serum.

W H Biggs, A C Wunderlich, L C Corbeil, C E Davis, J G Curd.   

Abstract

During routine addition of penicillinase (beta-lactamase) to patients sera, we found that the capacity of some of these sera to kill serum-sensitive gram-negative organisms was significantly decreased. Further controlled studies showed that penicillinase decreased both the bactericidal activity of normal human sera and the total hemolytic activity (CH50) of complement in these sera. The decreased bactericidal activity correlated significantly (r = 0.57, P less than 0.05) with the reduction of CH50 in eight normal sera. These effects of penicillinase were time and temperature dependent. Measurement of individual complement component activities showed that penicillinase decreased the activity of C2, C4, and C3-C9, suggesting that the penicillinase preparation activated the classical pathway. These results cast doubts on the validity of bactericidal determinations when sera are pretreated with penicillinase.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603195      PMCID: PMC184804          DOI: 10.1128/AAC.23.5.738

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  3 in total

1.  Structure and biosynthesis of the cell wall lipopolysaccharide of Escherichia coli.

Authors:  E C Heath; R M Mayer; R D Edstrom; C A Beaudreau
Journal:  Ann N Y Acad Sci       Date:  1966-06-30       Impact factor: 5.691

2.  Influence of colony type on susceptibility of gonococci to killing by human serum.

Authors:  J A McCutchan; S Levine; A I Braude
Journal:  J Immunol       Date:  1976-06       Impact factor: 5.422

3.  The role of C9 in complement-mediated killing of Neisseria.

Authors:  G R Harriman; A F Esser; E R Podack; A C Wunderlich; A I Braude; T F Lint; J G Curd
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.